GlassScriptPhysician profile
Glenn Anthony Brien
NPI 1760627996
$8,271.94
in general payments reported to CMS, 2019-2025
23 companies · $138 in 2025
The $138 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,380 · 2020: $265 · 2021: $2,779 · 2022: $444 · 2023: $239 · 2024: $2,026 · 2025: $138.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,511 · Food and Beverage: $892.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,511.44 |
| Food and Beverage | $892.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alon Medical Technology | $5,278.93 | 2019-2024 | |
| Arthrex, INC. | $1,059.70 | 2024 | |
| Pacira Therapeutics, INC. | $475.25 | 2019-2021 | |
| Stryker Corporation | $265.82 | 2021-2024 | Inspace, Mako |
| Bioventus LLC | $206.26 | 2020-2025 | Durolane, Durolane, Exogen Ultrasound Bone Healing System |
| Smith+Nephew, INC. | $198.15 | 2019-2022 | |
| Davol INC. | $166.90 | 2021-2023 | Arista Ah Flexitip |
| Horizon Therapeutics Plc | $110.26 | 2019-2021 | |
| Kowa Pharmaceuticals America, INC. | $75.54 | 2022-2023 | Seglentis |
| Kerecis Limited | $66.35 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Pacira Pharmaceuticals Incorporated | $59.24 | 2022-2025 | Zilretta, Iovera |
| Amgen INC. | $50.88 | 2021-2022 | |
| Vertex Pharmaceuticals Incorporated | $48.91 | 2025 | |
| Pfizer INC. | $28.10 | 2020 | |
| Zyla Life Sciences, INC. | $28.09 | 2020 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $27.17 | 2019 | |
| Ethicon US, LLC | $26.44 | 2024 | Ethicon |
| Vericel Corporation | $21.25 | 2022 | |
| Total Joint Orthopedics, INC. | $21.04 | 2024 | |
| Trevena, INC. | $18.78 | 2021 | |
| Radius Health, INC. | $13.38 | 2021 | |
| Ferring Pharmaceuticals INC. | $12.93 | 2020 | |
| Heron Therapeutics, INC. | $12.57 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Glenn Brien listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.